iRadimed Corp (NAS:IRMD)
$ 56.2 3.46 (6.56%) Market Cap: 712.25 Mil Enterprise Value: 616.94 Mil PE Ratio: 38.49 PB Ratio: 8.53 GF Score: 96/100

IRadimed Corp at JPMorgan Healthcare Conference Transcript

Jan 11, 2024 / 08:00PM GMT
Release Date Price: $45.74 (+1.28%)
Unidentified Participant

Well, good afternoon, everybody. Thank you so much for joining us. Today we have the opportunity to hear from Roger Susi, who is the Founder, President and CEO of IRadimed. He is also joined here to my left by Jack Glenn, the CFO of the company. They plan for about a 15 20-minute presentation followed by Q&A. So we'd love to hear your question to the extent that there are any from the audience.

Thank you.

Roger Susi IRadimed Corp;Founder
President & CEO

Thank you. Good afternoon and hello, everyone. Again, Roger Susi, I'm the President, Founder and CEO of IRadimed Corporation and Jack Glenn, our CFO, is here with me today. I'd like to point out that it's a first time for us at JPMorgan Conference. Though the company has been around for a number of years. We started business in 2005.

So before I get too far into what we're going to deliver today, we will be discussing some issues and an information that may be forward looking and so the obligatory disclosure. IRadimed is a public company, IRMD and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot